Cargando…

Additional chemotherapy improves survival in stage II–III pulmonary sarcomatoid carcinoma patients undergoing surgery: a propensity scoring matching analysis

BACKGROUND: The role of additional chemotherapy in pulmonary sarcomatoid carcinoma (PSC) is controversial. This study aimed to investigate the function of chemotherapy in PSC patients with surgical resection. METHODS: PSC patient information between 2004 to 2016 was extracted from the Surveillance,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cen, Yanhong, Yang, Chunxu, Ren, Jiangbo, Gong, Yan, Xie, Conghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859755/ https://www.ncbi.nlm.nih.gov/pubmed/33553317 http://dx.doi.org/10.21037/atm-20-3226

Ejemplares similares

Chemotherapy for advanced pulmonary sarcomatoid carcinoma: a population-based propensity score matching study
por: Wang, Feng, et al.
Publicado: (2023)

Prognostic value of the sarcomatoid component in bladder cancer: A propensity score matching study
por: Liu, Shuai, et al.
Publicado: (2023)

Survival of stage II nasopharyngeal carcinoma patients with or without concurrent chemotherapy: A propensity score matching study
por: Liu, Di‐Han, et al.
Publicado: (2019)

Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis
por: Song, Changhoon, et al.
Publicado: (2015)

Propensity-score matched comparison of partial versus radical nephrectomy for T1N0M0 sarcomatoid renal cell carcinoma
por: Ji, Bing, et al.
Publicado: (2020)

Chemotherapy exacerbates the survival paradox of colon cancer: a propensity score matching analysis
por: Tian, Mengxiang, et al.
Publicado: (2022)

Early stage ovarian immature teratoma, surveillance or chemotherapy after surgery? A propensity score matched analysis
por: Zhang, Xinyue, et al.
Publicado: (2022)

A Propensity Score-Matched Analysis for Non-Intubated Thoracic Surgery
por: Lan, Lan, et al.
Publicado: (2018)

VATS versus Open Lobectomy following Induction Therapy for Stage III NSCLC: A Propensity Score-Matched Analysis
por: Hireche, Kheira, et al.
Publicado: (2023)

Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis
por: Labrosse, Julie, et al.
Publicado: (2020)

Propensity‐score matching with competing risks in survival analysis
por: Austin, Peter C., et al.
Publicado: (2018)

Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis
por: Li, Qing, et al.
Publicado: (2022)

The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis
por: Zhi-Qiang, Wang, et al.
Publicado: (2019)

Stage IA Patients With Pancreatic Ductal Adenocarcinoma Cannot Benefit From Chemotherapy: A Propensity Score Matching Study
por: Zhang, Yuchao, et al.
Publicado: (2020)

Prognostic value of final pathological stage in colon adenocarcinoma after neoadjuvant chemotherapy: A propensity score-matched study
por: Xiang, Meijuan, et al.
Publicado: (2022)

Impact of thoracic radiation therapy after chemotherapy on survival in extensive‐stage small cell lung cancer: A propensity score‐matched analysis
por: Deng, Lei, et al.
Publicado: (2019)

Propensity score matching and complex surveys
por: Austin, Peter C, et al.
Publicado: (2016)

Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation
por: Chai, Yanfei, et al.
Publicado: (2021)

The prognostic value of gender in gastric gastrointestinal stromal tumors: a propensity score matching analysis
por: Rong, Jianfang, et al.
Publicado: (2020)

Propensity-score-matching-based analysis of laparoscopic gastrectomy with neoadjuvant chemotherapy for gastric carcinoma
por: Furuta, Shimpei, et al.
Publicado: (2021)

Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score Matching
por: Trommer, Maike, et al.
Publicado: (2020)

The impairment of induction chemotherapy for stage II nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy with or without concurrent chemotherapy: A propensity score‐matched analysis
por: Lai, YuLin, et al.
Publicado: (2022)

Effect of Early Adjuvant Chemotherapy on Survival of Advanced Gastric Cancer Patients: a Propensity Score-matched Analysis
por: Lee, Yoontaek, et al.
Publicado: (2018)

Survival Benefit of Perioperative Chemotherapy in Patients with Locally Advanced Gastric Cancer: a Propensity Score Matched Analysis
por: Eom, Bang Wool, et al.
Publicado: (2018)

Long-Term Survival of Neuroblastoma Patients Receiving Surgery, Chemotherapy, and Radiotherapy: A Propensity Score Matching Study
por: Li, Qilan, et al.
Publicado: (2023)

Prognostic value of chemotherapy in addition to concurrent chemoradiotherapy in T3-4N0-1 nasopharyngeal carcinoma: a propensity score matching study
por: Wu, Li-Rong, et al.
Publicado: (2017)

Head to head comparison of the propensity score and the high-dimensional propensity score matching methods
por: Guertin, Jason R., et al.
Publicado: (2016)

Surgery as a Potential Treatment Option for Patients With Stage III Small-Cell Lung Cancer: A Propensity Score Matching Analysis
por: Zhang, Chenyue, et al.
Publicado: (2019)

The prognostic value of including S-1 regimens in stage II and III gastric cancer patients: A propensity score matching and subgroup analyses
por: Li, Yifan, et al.
Publicado: (2023)

Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort
por: Sun, Xue‐Song, et al.
Publicado: (2019)

Hypofractionated Radiotherapy for Early-Stage Breast Cancer: A Propensity Score Matched Analysis
por: Lee, Anbok, et al.
Publicado: (2022)

Perioperative chemotherapy in colorectal cancer with peritoneal metastases: A global propensity score matched study
por: Cashin, Peter H., et al.
Publicado: (2022)

Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
por: Wang, Fangzheng, et al.
Publicado: (2018)

Propensity Score-Matched Analysis of the Survival Benefit from Kidney Transplantation in Patients with End-Stage Renal Disease
por: Wu, Ming-Ju, et al.
Publicado: (2018)

Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database
por: Zhang, Rui, et al.
Publicado: (2018)

Addition of anaerobic coverage for treatment of biliary tract infections: a propensity score-matched cohort study
por: Simeonova, Marina, et al.
Publicado: (2023)

Association Between Chemotherapy and Survival in T1 Colon Cancer With Lymph Node Metastasis: A Propensity-Score Matched Analysis
por: Yan, Wangxin, et al.
Publicado: (2021)

Major clinical benefit from adjuvant chemotherapy for stage II–III non-small cell lung cancer patients aged 75 years or older: a propensity score-matched analysis
por: Blasi, Miriam, et al.
Publicado: (2022)

Adjuvant Therapy for High-Risk Stage II or III Colon Adenocarcinoma: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study
por: Chang, Chia-Lun, et al.
Publicado: (2019)

Survival benefits with EPIC in addition to HIPEC for low grade appendiceal neoplasms with pseudomyxoma peritonei: a propensity score matched study
por: Hayler, Raymond, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gsj31lpcvg5tqhtb7jbvdc7cr3